Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Results Details (267)

Name Institution Why
Donald William Kufe, M.D.Dana-Farber Cancer Institute Why?
Zhi-Min Yuan, Ph.D.Harvard T.H. Chan School of Public Health Why?
Nathanael Gray, Ph.D.Dana-Farber Cancer Institute Why?
Elham Karimizadeh, Ph.D.Brigham and Women's Hospital Why?
James Douglas Griffin, M.D.Dana-Farber Cancer Institute Why?
Philip Arthur Cole, M.D.,Ph.D.Harvard Insitutes of Medicine Why?
Patrick Michael Reeves, Ph.D.Massachusetts General Hospital Why?
Anna Margaret Schmoker, Ph.D.Dana-Farber Cancer Institute Why?
Banyuhay P. Serrano, Ph.D.Harvard Medical School Why?
George Quentin Daley, M.D., Ph.D.Harvard Medical School Why?
William George Kaelin, M.D.Dana-Farber Cancer Institute Why?
Ross Stuart Berkowitz, M.D.Brigham and Women's Hospital Why?
Bryan Thomas Ciccarelli, M.D.Brigham and Women's Hospital Why?
Surender Mohan Kharbanda, Ph.D., Ph.D.Dana-Farber Cancer Institute Why?
Demetrios Vavvas, M.D.,Ph.D.Massachusetts Eye and Ear Infirmary Why?
Per Page    Page  of 18last Nextnext
Search Criteria
  • Oncogene Proteins v abl
Click "Why?" to see why a person matched the search.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.